Immunocompromised people are still shielding

Diana, a 63-year-old kidney and pancreas transplant recipient and retired nurse, has been shielding throughout the pandemic, missing precious moments with loved ones. Monthly eye injections are preserving her sight, but Evusheld/Sipavibart could give her the freedom to enjoy the years she has left before she loses her sight.

Meet Shannon, a 50-year-old lupus survivor and founder of Be Leadership. Once a globe-trotting professional, she now shields as she cannot take preventative COVID-19 medications due to her condition. Despite her team's return to in-person work, Shannon remains isolated, unable to receive further vaccinations or antiviral treatments. With Evusheld/Sipavibart, she hopes to reunite with her family and reduce her risks.

Martin is a 36-year-old university professor with rheumatoid arthritis and vasculitis. Pre-pandemic, Martin travelled the world for speaking engagements, but since 2020, he's been isolated, relying on remote work and walks with his dog, Toby. Despite five vaccinations, he lacks COVID-19 antibody protection and remains shielding, unable to travel for work. Evusheld/Sipavibart offers Martin hope for a return to normalcy.

Chloe’s life changed drastically after health conditions led to a liver transplant in 2007. COVID-19 forced her into shielding, halting her successful B&B business and her husband's plastering work. Financial struggles ensued, forcing them to sell their home and rely on savings. Chloe longs to return to work and normalcy, but her health remains a risk. Evusheld/Sipavibart offers hope for reclaiming her life and simple joys like dining out.